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Myokines are muscle-secreted factors to regulate cellular functions. However, it remains
elusive what type of myokine is released during muscle differentiation. Here we evaluated
the dynamics of myokines. More than 400 proteins were detected in conditioned medium
and approximately 8% of them were categorized as myokines. The levels of myokines
which promote myotube formation, vascularization or neurogenesis peaked during early
differentiation, whereas myokines contributing to repellent activity against nerve cells
or suppression of adipogenesis decreased after differentiation. Our ﬁndings suggest that
muscle cells secrete different types of myokines at different developmental stages to com-yokine
keletal muscle
roteome
rowth factor
ifferentiation
municate with various types of cells.
© 2014 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
Association (EuPA). This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
mass caused by hypertrophy and hyperplasia [7,8]. These. Introduction
keletal muscles are able to alter their phenotypes, i.e.,
ypertrophy and atrophy, in response to biological growth
nd physical exercise. Growth factors are largely involved
n these processes. In particular, insulin-like growth fac-
or 1 (IGF-1) increases skeletal muscle mass in vitro and
n vivo through protein synthesis pathways [1], and increases
yoblast recruitment to fusion [2–4]. Hepatocyte growth
Abbreviations: CM, conditionedmedium;DM, differentiationmedium
ags for relative and absolute quantitation; MS, mass spectrometry.
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rticle under the CC BY-NC-ND license (http://creativecommons.org/licfactor (HGF) stimulates activation of satellite cells, which
are skeletal muscle stem cells residing in a quiescent state
[5]. In contrast to IGF-1 and HGF, myostatin, a transforming
growth factor (TGF)- family member, suppresses satellite
cell activation and myoblast proliferation [6]. Loss of myo-
statin function leads to a signiﬁcant increase in muscle; ECM, extracellularmatrix; GM, growthmedium; iTRAQ®, isobaric
growth factors, which are secreted by skeletal muscle and
other tissues, directly affect skeletal muscle growth and
hypertrophy.
European Proteomics Association (EuPA). This is an open access
enses/by-nc-nd/3.0/).
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Recently, it has beenproposed that “myokines” are proteins
or peptides released from skeletal muscle cells to modulate
the metabolic process in muscle and other tissues [9]. When
skeletal muscles undergo physiological exercise, interleukin
6 (IL-6) secreted by skeletal muscle cells increases in serum
[10], inﬂuencing glucose homeostasis during exercise [11]. In
addition to IL-6, IL-8, and other cytokines are also regulated by
concentricmuscle contraction in vivo and electric pulse stimu-
lated culturedmyotubes in vitro [12,13]. Althoughphysiological
function of IL-8 within muscle tissue is poorly understood, it
acts as an angiogenic factor and a chemokine in other tissues.
This evidence indicates that skeletal muscle tissue functions
as an endocrine organ that secretes myokines, like adipose
tissue that secretes adipokines.
Mononucleated skeletal muscle cells, i.e., myoblasts,
increase their numbers in mitogen-rich growth conditions,
but stop proliferating to formmultinucleatedmyotubes in low
mitogen conditions. In this way, myoblasts are very sensitive
to mitogen, including growth factors and possibly myokines.
Mature myotubes also become much larger than mononu-
cleated myoblasts and juvenile myotubes. This increase in
myotube or myoﬁber size occurs even in in vitro culture sys-
tems, which are independent from the blood vascular system,
strongly suggesting that muscle cells secrete proteins and
peptides to effectively stimulate their differentiation in an
autocrine fashion.
We test the hypothesis that muscle cells secrete differ-
ent types of myokines at different myogenic growth and
differentiation stages. Muscle cell-secreted proteins and pep-
tides collected from four culture stages were comprehensively
identiﬁed and quantitatively analyzed using matrix-assisted
laser desorption/ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS) and tandem mass spectrometry (MS/MS)
with iTRAQ® labeling. The iTRAQ® proﬁle revealed the dynam-
ics ofmyokines duringmuscle cell growth and differentiation.
2. Materials and methods
2.1. Cell culture
Animals were cared for according to the procedures outlined
in the Guide for the Care and Use of Experimental Animals
(Animal Care Committee of the NARO Institute of Livestock
and Grassland Science), and was approved by the committee.
Mouse satellite cells were prepared as previously described
with modiﬁcations [14]. In brief, nerves, blood vessels, ten-
dons, and fat tissues were removed from hindlimb muscles.
Minced muscles were treated with 0.2% type II collagenase
(Worthington Biochemical, Lakewood, NJ) for 40min at 37 ◦C.
Muscle slurries were ﬁltered through 100mand 40mnitrex
meshes (BD Bioscience). Skeletal muscle cells were cultured
on collagen-coated 90mm dishes (Asahi Techno Glass) in pro-
liferatingmedium (20% fetal bovine serum [FBS] and 2.5ng/ml
of b-FGF [Life Technologies] in F10Medium [Life Technologies])
to proliferate thenumber of cells. Thesemuscle cellswere sub-
cultured for further analyses. Cells were shifted from growth
medium (GM; 20% FBS in DMEM [Life Technologies]) to dif-
ferentiation medium (DM; 5% horse serum [HS] in DMEM) to
induce muscle differentiation. DM was changed every othercs 5 ( 2 0 1 4 ) 1–9
day. All media were supplemented with 100U/ml penicillin,
0.1mg/ml streptomycin, and 2mM l-glutamine (Life Tech-
nologies). FBS and HS were ﬁltered with a 0.45m ﬁlter before
use to remove debris.
2.2. Medium collection
Conditioned media (CM) were collected from cultured cells in
growing conditions and in differentiation conditions at 30, 72,
and 120h after an induction of myogenic differentiation. At
each point of collecting CM, cells were rinsed with 37 ◦C PBS
at least 3 times to eliminate serum contamination. Then, cells
were rinsed with DMEM that was kept in a cell incubator to
adjust pH and temperature (37 ◦C) at least 1 day before use.
Cells were incubated with 5mL of DMEM per 90mm dish for
1h. Morphological changes of cultured cells were not detected
during this treatment. The CM were collected, centrifuged,
and ﬁltered using 0.2m ﬁlters (Sartorius) to ensure removal
of any debris. The CM were concentrated using spin columns
with a cutoff of 3 kDa (Millipore) and stored in a −80 ◦C freezer.
We collected 250–500mL of conditioned media at each cul-
ture stage (G, D30h, D72h andD120h). Namely, 50–100×90mm
culture dishes were utilized at each culture stage. Because of
low yields of specimens, we performed a single experiment
of iTRAQ labeling and MS analysis. Protein concentration was
quantiﬁed using the Bradford protein assay (Bio-Rad). Equiv-
alent amounts of secreted proteins in CM were subjected to
SDS–PAGE and a gel was stained with SYPRO® Ruby (Bio-Rad).
The SYPRO® Ruby ﬂuorescent signals were scanned with the
Ettan DIGE imaging system (GE Healthcare).
2.3. Immunoblot and antibodies
Cells were harvested with cell scrapers in the presence of
homogenizing buffer (0.15M CsCl, 10mM Tris/Cl [pH 7.5],
0.1mM EDTA-Cs [pH 8.0], 1mM dithiothreitol, 28M E64
[Peptide Inst.], 1.5mM aprotinin [Sigma], 0.1mM leupeptin
[Peptide Inst.], 0.7mM calpastatin [Takara], 40M bestatin
[Sigma], and 2mM phenylmethylsulfonyl ﬂuoride [Sigma]).
Whole cell lysates were separated by SDS–PAGE and trans-
ferred to Immobilon-P transfer membranes (Millipore) as
previously described [15]. After blocking with 0.5% nonfat
skim milk in PBS, membranes were incubated with mouse
anti-embryonic myosin heavy chain antibody (1:250 dilution;
clone#F1.652 developedbyDr.H.M. Blau andobtained from the
Developmental Studies Hybridoma Bank; [16]). Subsequently,
membranes were incubated with peroxidase-conjugated sec-
ondary antibodies (1:10 dilution; Nichirei), and the reacted
bands were visualized using a POD immunostaining kit (Wako
Pure Chemical Industries).
2.4. MS sample preparation and MS analysis
Twenty micrograms of CM proteins from each time point
were dissolved in 20L of 0.5M triethylammonium bicarbon-
ate containing 0.1% Rapigest (Waters). The iTRAQ® labeling
method was previously described [15,17]. In brief, each
specimen was reduced by TCEP, alkylated by MMTS, and
digested by trypsin (Promega) prior to labeling with iTRAQ®
4-plex reagent (ABSciex) according to the manufacturer’s
e u pa open proteomic
Fig. 1 – A scheme of the experimental design. An
experimental overview is shown. Conditioned media (CM)
were collected from growth phase (G), and 30h (D30h), 72h
(D72h), and 120h (D120h) after muscle differentiation.
Concentrated CM were labeled with iTRAQ® following
trypsin digestion. Two-dimensional peptide fractionation
was performed and each fraction was analyzed with a
mass spectrometer. A total of 437 proteins with a Mascot
score greater than 45 were identiﬁed and quantiﬁed from
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tomeP (http://www.cbs.dtu.dk/services/SecretomeP/) [19] pre-814 spectra by a Mascot search engine.
nstructions. Samples prepared from growth conditions (G),
0h DM (D30h), 72h DM (D72h), and 120h DM (D120h) were
abeledwith iTRAQ® 114, 115, 116, and 117, respectively (Fig. 1).
TRAQ® labeled specimens were combined and then multi-
tep peptide fractionation was performedwith a strong cation
xchange column (ABSciex). Eight total fractions were eluted
ith 20, 50, 75, 100, 150, 200, 350, and 500mM KCl. Every spec-
men was desalted using a Sep-Pak cartridge (Waters) and
oncentrated with a vacuum centrifugal concentrator.
Peptide fractionation was further performed on a nano-
ow LC system equippedwith aMALDI-plate spotter (Chorus).
eptides trapped on a trap column (0.3mm×5mm, 5m,
2nm, l-columnODS; CERI, Tokyo, Japan) were separated onto
n analytical column (0.075mm×50mm) packed with Magic
18AQ resin (3m, 10nm particles; Michrom Bioresources);
hey were eluted with acetonitrile using a gradient of 5–40%
olvent B in solvent A for 60min (solvent A: 1.2% acetonitrile,
.1% TFA; solvent B: 81.2% acetonitrile, 0.1% TFA), 40–100% sol-
ent B in solvent A for 20min, and 100% solvent B for 10min.
he column efﬂuent was mixed with the MALDI matrix solu-
ion (2mg/mL -cyano-4-hydroxycinnamic acid [Shimadzu]
issolved in 70% acetonitrile containing 0.1% TFA) at a rate
f 1.8L/min at the outlet, and spotted directly onto the ABI
800 MALDI-plates (ABSciex).
Spotted fractions corresponding to eight gradient seg-
ents in SCX chromatography (192×8=1536 spots) were
nalyzed with a mass spectrometer (ABSciex 4800 plus
ALDI TOF/TOF Analyzer). Proteins were identiﬁed using an
n-house Mascot search engine (ver. 2.4.0, Matrix Science)
nd the NCBI database (20,571,509 sequences; 7,061,663,751
esidues; Jan. 10, 2013). Mascot search criteria were as follows:
nzyme, “none”; Fixed modiﬁcations, “iTRAQ4plex (N-term)”
nd “iTRAQ4plex (K)”; Variable modiﬁcations, “Deamidated
NQ)”, “Oxidation (M)”, “MMTS (C)” and “iTRAQ4plex (Y)”; Pep-
ide mass tolerance, “±100ppm”; Fragment mass tolerance,
±0.25Da”. The Mascot search engine detected 437 proteins
ith a Mascot score above 45 from 8814 MS/MS spectra. Each
ascot score of identiﬁed protein in Fig. 4 was greater than 66.s 5 ( 2 0 1 4 ) 1–9 3
3. Results and discussion
3.1. Proteins secreted during muscle growth and
differentiation
Wehypothesized thatmuscle cells secrete differentmolecules
at different myogenic developmental stages since prolifer-
ating myoblasts and multinucleated myotubes have distinct
properties. We comprehensively detected and quantitatively
evaluated secreted proteins and peptides in cultured media
using a mass spectrometer and iTRAQ® labeling (Fig. 1). We
observed morphological alteration of mouse skeletal muscle
cells during myogenic differentiation (Fig. 2a). Muscle cells
increased in number in growth conditions (G in Fig. 2a),
but myoblasts fused to form myotubes following induction
of muscle differentiation. Myotubes formed consistently at
72h after differentiation (D72h) and spontaneous contraction
was often observed in myotubes at 120h after differentiation
(D120h). Next, we examined the expression of myosin heavy
chain, which is one of the best markers of muscle differen-
tiation. Immunoblot analysis using anti-embryonic myosin
heavy chain conﬁrmed higher expression levels of myosin at
late stages of development (Fig. 2b). These results demon-
strated that muscle cells were successfully differentiated.
3.2. Comprehensive identiﬁcation of secreted proteins
and peptides by MS/MS analysis
To avoid contamination, serum-free conditioned media were
used in this experiment. These culture media were collected
and qualities of each were examined by SDS–PAGE (Fig. 3a).
The band patterns for the growth stage were completely
different from those for the differentiation stages. Among
specimens of muscle differentiation, distinct intensities of
bands were observed. These results suggest that muscle cells
secreted different types and amounts of proteins and peptides
at growth and every differentiation stage.
To comprehensively and quantitatively evaluate what type
of proteins and peptideswere secreted by skeletalmuscle cells
during differentiation, those in cultured medium were ana-
lyzed with a mass spectrometer after labeling with iTRAQ®.
A total of 437 proteins or peptides were identiﬁed from 8814
MS/MS spectra using theMascot search engine. Theseproteins
and peptides were categorized by their original localizations
using gene ontology (Fig. 3b). Approximately 8% of identiﬁed
proteins and peptideswere derived from extracellular regions;
76% were of cytoplasmic origin; and 12% were membrane-
associated proteins. Unknown proteins and contamination
with serum proteins accounted for 1% and 3%, respectively.
Based on gene ontology classiﬁcation, less than 10% of pro-
teins were deﬁned as secreted proteins. Therefore our data
were further evaluated using web-based bioinformatics tools.
The SignalP (http://www.cbs.dtu.dk/services/SignalP/) [18]
predicted that about 10% of identiﬁed proteins contained typi-
cal signal peptide sequence (Supplemental Fig. S1). The Secre-dicted that about 43% of identiﬁed proteins were classiﬁed
as non-classical secreted proteins that can be exported
without a classical N-terminal signal peptide (Supplemental
4 e u pa open proteomics 5 ( 2 0 1 4 ) 1–9
Fig. 2 – Morphological and qualitative alterations of mouse
cultured skeletal muscle cells during myogenic
differentiation. (a) Light microscopy-based images of
muscle cells cultured in growth medium (G), and in
differentiation medium at 30h (D30h), 72h (D72h), and
120h (D120h) are shown. Scale bars represent 100m. (b)
Immunoblot was carried out using anti-embryonic myosin
heavy chain antibody. Whole cell lysates prepared from
cultured muscle cells in growth medium (G), and in
differentiation medium at D30h, D72h, and D120h were
subjected to SDS–PAGE. Subsequently, immunoblot was
carried out to detect embryonic myosin heavy chain. The
black arrowhead indicates bands corresponding to
embryonic myosin heavy chain.
Fig. 3 – Secreted proteins and their subcellular
localizations. (a) Equivalent amounts of secreted proteins
(1g) from each sample (G, D30h, D72h, and D120h) were
subjected to SDS–PAGE, and subsequently stained with
SYPRO® Ruby. (b) Identiﬁed proteins and peptides are
categorized by subcellular localizations, which are
determined based on the ontology of the National Center
for Biotechnology Information. Secreted proteins were
involved in the extracellular region. Note that some
proteins have multiple cellular localizations.
Fig. S1). Furthermore, proteins in exosomes that are small
vesicles to shuttle between cells were veriﬁed by the Exo-
Carta (http://www.exocarta.org/) [20]. Approximately 65% of
identiﬁed proteins were detected as exosomal proteins (Sup-
plemental Fig. S1).
Proteins and peptides localized to the extracellular region
based on gene ontology classiﬁcation were further classiﬁed
e u pa open proteomics 5 ( 2 0 1 4 ) 1–9 5
Fig. 4 – A list of secreted proteins and peptides categorized by functions. Secreted proteins and peptides from the
extracellular region were further classiﬁed into four types based on their functions: growth factor activity, extracellular
matrix (ECM) component, protease inhibitor, and other (including unknown). iTRAQ® signal intensities of identiﬁed
proteins and peptides at each point of muscle differentiation were normalized with iTRAQ® signal intensities at growth
condition. Proteins and peptides that increased more than 2-fold during muscle differentiation are shown in red rows.
Proteins and peptides that decreased less than 2-fold during muscle differentiation are shown in blue rows. Standard
geometric deviation (SD) is used. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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mnto four groups by their functions. The number of identiﬁed
roteins or peptides in the categories of growth factor activity,
CM component, protease inhibitor, and others were 12, 9, 5,
nd 10, respectively (Fig. 4). We quantiﬁed proteins and pep-
ides normalized with iTRAQ® reporter signal intensities for
he growth condition. Seventeenproteins increasedmore than
-fold during muscle differentiation (red rows in Fig. 4). Four
roteins or peptides decreased less than 2-fold during mus-
le differentiation (blue rows in Fig. 4). iTRAQ® data showed
hree main patterns of secreted protein or peptide proﬁles.
he ﬁrst pattern peaks for the growth condition and gradually
eclines during muscle differentiation. The second pattern
s a peak at D30h or D72h. The last pattern is characterized
y a peak at late differentiation, D120h. Most of the proteins
hat localized to the extracellular region are consistent with
he second pattern, indicating that myogenic differentiation
acilitates myokine release.
.3. Identiﬁed secreted proteins and peptides: growth
actor activityrolactin-2C3, semaphorin-7A (Sema7A), and follistatin-
elated protein 1 decreased in signal intensity during
uscle differentiation. This suggests that these proteins maybe necessary during muscle cell proliferation rather than
muscle differentiation. In particular, the Sema family
functions as chemorepellent against nerve cells during neu-
romuscular junction formation in vivo [21]. Some types of
semaphorins are expressed not only in nerve cells, but
also skeletal muscle cells [22–24]. Tatsumi et al. [23] pro-
pose that satellite cell derived-myoblasts secrete Sema3A,
which is triggered by HGF and is highly expressed during
the myoblast proliferating stage, to prevent the interaction
between motor neuron and immature muscle cells until
myotubes or myoﬁbers mature. Our results also showed that
proliferating myoblasts secreted semaphorin, and it may be a
signal to avoid the interaction between muscle cells and neu-
rons, although the precise functions of Sema7A in developing
skeletal muscles are not known.
We detected seven proteins with peaks of growth fac-
tor activity at D30h or D72h in our iTRAQ® data (Fig. 4).
These proteins are thought to be involved in accelerat-
ing muscle differentiation because of the changes in their
secreted amounts during muscle differentiation. In fact, at
least three of them, galectin-1 (Lgals1), prosaposin (Psap), and
high-mobility groupprotein 1 (Hmgb1), promotemuscle differ-
entiation andmyoﬁber formation [25–27]. Intriguingly, Hmgb1
is important in inﬂammatory response since it is released
eomi6 e u pa open prot
from inﬂammatory cells and is thought to be a lymphokine
[28]. However, our results and those of other studies [29] show
thatHmgb1 is released fromdifferentiatingmuscle cells. Thus,
it has multiple functions, including as a myokine to enhance
myoﬁber formation and as a lymphokine to promote inﬂam-
mation.
We captured a characteristic secretion pattern for secreted
protein acidic and rich in cysteine (Sparc, also known as
osteonectin or BM-40) during muscle differentiation. Sparc
increased approximately 1.6-fold at D30h but subsequently
decreased (G:D30h:D72h:D120h=1.00:1.56:0.84:0.58). Our data
support previous reports that Sparc is expressed in both
myoblasts and myotubes [30,31]. When Sparc expression is
knocked down using siRNA, myogenesis was reduced [32].
These results suggest that Sparc secreted by proliferating
muscle cells promotesmuscle differentiation. It is also associ-
ated with adipocyte maturation, obesity, and diabetes [32–34].
Combined, Sparc secreted by muscle cells facilitates muscle
development through the suppression of adipogenic differen-
tiation in skeletal muscle tissues consisting of both muscle
cells and progenitors of adipocyte [35].
C1q and tumor necrosis factor related protein 3 (C1qtnf3)
is an adiponectin paralogous adipokine [36,37]. It is speciﬁ-
cally induced during late adipocyte differentiation and plays a
role in maintaining adipogenic differentiation [38]. We found
that C1qtnf3 was produced by muscle cells, particularly after
differentiation, and it is 3-fold more abundant during differ-
entiation than that in the growth stage. Thus, it is possible
that muscle cells secrete it during muscle differentiation to
prevent the induction of adipogenic differentiation in in vivo
skeletal muscle development.
Hepatoma-derived growth factor (Hdgf) is a novel angio-
genic secreted factor [39].We found that secretionofHdgf from
muscle cells peaked at D72h. Although its effects on muscle
differentiation are not fully understood, Hdgf is secreted from
myotubes or myoﬁbers, possibly to promote angiogenesis in
skeletal muscle tissues in vivo. Hmgb1 also enhances vascu-
larization [29], whereas Sparc suppresses angiogenesis [40].
These functions are reﬂected in their secretion levels during
muscle differentiation, because Hdgf and Hmgb1 peaked at
D72h, but Sparc decreased during late muscle differentiation.
3.4. Identiﬁed secreted proteins and peptides: ECM
components and Protease inhibitors
In skeletal muscle tissue, each myoﬁber is surrounded by the
basement membrane. We detected heparan sulfate proteo-
glycan 2 (Hspg2; also called perlecan) and laminin gamma
subunit (Lamc2), both of which are major components
of the basement membrane. Secretion of both drastically
increased just after induction of muscle differentiation. We
also found glypican (Gpc1), which is a glycosylphosphatidyli-
nositol (GPI)-anchored heparan sulfate proteoglycan. Secreted
Gpc1 increased 4-fold at D30h compared to its level at the
growth condition. This is consistent with the idea that the
shedding of Gpc-1 from the satellite cell surface acts as a
positive regulator of satellite cell differentiation [41]. Hspg2
not only functions as a component of the basement mem-
brane, but also interacts with superoxide dismutase 3 (Sod3)
to prevent cell damage initiated by extracellularly producedcs 5 ( 2 0 1 4 ) 1–9
reactive oxygen species [42]. We found that secreted levels of
Sod3peakedduring earlymuscle differentiation. These results
suggest that Hspg2 and its associated proteins were released
from muscle cells synchronously to efﬁciently construct the
extracellular environment.
We also found collagen  subunits of type I andV thatmake
up the endomysium and perimysium in skeletal muscle tis-
sues. Type I collagen interacts with biglycan, a member of the
class I family of small leucine-rich proteoglycans, to organize
the assembly of collagen ﬁbrils [43,44]. We detected secreted
biglycan at the proliferating and early differentiation stages
of muscle cell development, consistent with previous reports
that mRNA expression of biglycan is initially high and then
decreases during skeletal muscle differentiation and matura-
tion [45]. Most other ECM components detected in this study
were highly secreted following the induction of muscle differ-
entiation, indicating that muscle cells produce extracellular
components to build up ECM architecture along withmyotube
and myoﬁber formation.
Sushi, von Willebrand factor type A, EGF, and pentraxin
domain containing 1 (Svep1) were found from the early
phases of myogenic differentiation through myotube for-
mation. Our quantitative iTRAQ data (G:D30h:D72h:D120h=
1.00:1.03:1.48:1.19) were in agreement with data from a previ-
ous study that shows a decline of Svep1 expression in mature
myotubes or myoﬁbers [46]. We also detected an increase in
Svep1 at D72h, when myogenic cells fuse to form myotubes.
Svep1 is thought to be involved in muscle cell fusion through
its interactionwith 91 integrin and Adam 12, because Svep1
is a ligand for 91 integrin [47], which interacts with Adam12
during muscle differentiation [48].
Tissue inhibitor of metalloproteinase 2 (Timp2) was also
observed, and increased considerably during early mus-
cle differentiation. While matrix metalloproteinase (MMP) is
involved in the degradation of the extracellular matrix, Timp2
inhibits the breakdown of ECM structures, which function as
scaffolds for myotubes or myoﬁbers. In other words, muscle
cells facilitate the production of ECM components to assem-
ble ECM structures by secreting collagens and proteoglycans,
and protect ECM components by inhibition of MMP. Further-
more, Timp2 may also affect muscle cell motility, promoting
the formation of myotubes or myoﬁbers [49].
Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin,
pigment epithelium-derived factor), member 1 (Serpinf1; also
called pigment epithelium-derived factor [PEDF]) is catego-
rized as a protease inhibitor but does not display protease
inhibitory activity. It negatively regulates angiogenesis [50].
Our iTRAQ® data showed that Serpinf1 decreases at late differ-
entiation. This pattern of secretion is identical to Sparc, which
functions in anti-neovascularization.
3.5. Positive functions of myoﬁbril components in
muscle cell growth
Unexpectedly, approximately 76% of the identiﬁed proteins
were derived from cytoplasm by gene ontology classiﬁcation
(Fig. 3). Other groups have also reported cytoplasmic com-
ponents in secreted fractions by MS/MS analyses [24,51,52].
One of the reasons that high percentage of cytoplasmic pro-
teinswere detectedmight be caused by cell damages including
e u pa open proteomics 5 ( 2 0 1 4 ) 1–9 7
Table 1 – Relative quantiﬁcation of immunoglobulin domain containing myoﬁbrillar proteins during muscle
differentiation.
GI# Gene Name iTRAQ signal ratio Counted peptides
G/G D30h/G D72h/G D120h/G
77812697 Ttn Titin isoform N2-A 1.00 2.86 6.69 10.98 3
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(339896547 Mybpc1 Myosin binding protein C 1.00
109730993 Mybph Myosin binding protein H 1.00
poptotic cell death occurring after the induction of mus-
le differentiation [53]. The other possibility is that some
ytosolic proteins classiﬁed by gene ontologymay have poten-
ial to be localized to extracellular space. Since the SecretomeP
nd the ExoCarta predicted about 43% and about 65% of pro-
eins that have potential to be exported to extracellular space
ithout classicalN-terminal signal peptide (Supplemental Fig.
1). These data suggest that skeletal muscle cells release pro-
eins through not only classical signal peptide pathway but
lso non classical secretion pathways including exosome.
More interestingly, it has been proposed that titin,
yosin binding protein C, and myomesin, which are each
mmunoglobulin domain containing myoﬁbrillar proteins of
keletal muscles, activate the expression of IGF splicing vari-
nts, stimulating myoblast proliferation [54]. We also found
ragments of titin, myosin binding protein C andmyosin bind-
ng protein H, an isoform of myosin binding protein C, in our
TRAQ® data (Table 1). Because the immunoglobulin domain
s involved in cell adhesion and binds to cell surface receptors,
hese fragments of myoﬁbrils may trigger signal transduc-
ion of cell proliferation and/or differentiation. The mitogenic
ctivity factor is also found in an extract of crushed adultmus-
les [55]. Thus, myoﬁbril fractions in the extracellular region
ight promote muscle cell proliferation and/or differentia-
ion, although it remains controversial how these proteins are
xported to the extracellular space.
ig. 5 – A scheme of muscle cell-secreted myokines during
uscle differentiation. Skeletal muscle cells secreted
ifferent type of myokines at different muscle
ifferentiation stages. Proliferating muscle cells secreted
yokines that mainly function as neuronal repellents
Sema7a) and in anti-adipogenic differentiation (Sparc).
uring early differentiation, muscle cells produced
yokines that facilitate myotube/myoﬁber formation
Sparc, Lgals1, Psap, Hmgb1 and Timp2), vascularization
Hdgf and Hmgb1), and neurogenesis (Hdgf and Psap).
r1.36 2.72 5.40 1
2.56 6.48 5.32 1
4. Conclusions
We found that cultured skeletal muscle cells produced
different types and amounts of myokines during muscle dif-
ferentiation. During the proliferating stage, muscle cells tend
to secrete myokines that suppress neurogenesis and adipoge-
nesis. Asmuscle differentiation proceeds,muscle cells release
myokines that speciﬁcally promote myotube formation, vas-
cularization and neurogenesis (Fig. 5). As skeletal muscle
tissue consists of not only skeletal muscle cells but also other
types of cells, including nerve cells, fat cells, and endothelial
cells, the complicated skeletalmuscle tissuemust be precisely
regulated by these types of cells. Our data suggest that skeletal
muscle cells take advantage ofmyokines as signals to organize
skeletal muscle tissue even in vitro.
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